Comparing BPC-157 to PRP, Stem Cell Therapy, and Advanced Regenerative Treatments Platelet-Rich Plasma (PRP) Therapy Derived from the patients own blood and concentrated to deliver high levels of growth factors directly to injured areas
NO-releasing agents, such as JS-K ( O 2 -(2,4-dinitrophenyl)-1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate) 123 and PABA/NO ( O 2 -[2,4-dinitro-5-( N -methyl- N -4 carboxyphenylamino)phenyl] 1- N , N -dimethylamino)diazen-1-ium-1,2-diolate) 124 , are able to induce differentiation and cell death in a variety of cancer cells through GSH consumption, DNA synthesis inhibition and inhibition of enzymes involved in the defense against cell damage
are also supported by the German Centre for Cardiovascular Research (DZHK) partner site project
Vitamin deficiencies, DNA changes, and blood vessel damage harm the placenta, raising the risk of high blood pressure, preeclampsia, and other complications for mother and baby